Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1696 AL 1710

Synaptic vesicle endocytosis deficits underlie GBA-linked cognitive dysfunction in Parkinson's disease and Dementia with Lewy bodies

Vidyadhara DJ, Bäckström D, Chakraborty R, Ruan J, Park JM, Mistry PK, Chandra SS.

bioRxiv [Preprint]. 2025 Jan 2:2024.10.23.619548. doi: 10.1101/2024.10.23.619548.

Typology of sexual disorders in idiopathic Parkinson's disease, a systematic review

Salardaine Q.

Fr J Urol. 2025 Mar;35(2):102796. doi: 10.1016/j.fjurol.2024.102796. Epub 2024 Oct 28.

Application of computational algorithms for single-cell RNA-seq and ATAC-seq in neurodegenerative diseases

Choi H, Kim H, Chung H, Lee DS, Kim J.

Brief Funct Genomics. 2025 Jan 15;24:elae044. doi: 10.1093/bfgp/elae044.

Dopamine Cell-Based Replacement Therapies

Kayhanian S, Barker RA.

Cold Spring Harb Perspect Med. 2025 Aug 1;15(8):a041611. doi: 10.1101/cshperspect.a041611.

Gut microbiota and Parkinson's disease

Wang L, Cui Y, Han B, Du Y, Salewala KS, Wang S, Zhao W, Zhang H, Wang S, Xu X, Ma J, Zhu Y, Tuo H.

Chin Med J (Engl). 2025 Feb 5;138(3):289-297. doi: 10.1097/CM9.0000000000003318. Epub 2024 Nov 6.

Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B Inhibitors

Rana N, Grover P.

CNS Neurol Disord Drug Targets. 2025;24(4):263-284. doi: 10.2174/0118715273340983241018095529.

Causal Mediation Analysis of Factors Influencing Physical Activity and Community Access Among People With Mild-to-Moderate Parkinson Disease

Paul SS, Porciuncula F, Cavanaugh JT, Rawson KS, Nordahl TJ, Baker TC, Duncan RP, Earhart GM, Ellis TD.

Arch Phys Med Rehabil. 2025 Jun;106(6):871-879. doi: 10.1016/j.apmr.2024.10.012. Epub 2024 Nov 5.

Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship

Antelmi E, Lanza G, Mogavero MP, Mingolla GP, Plazzi G, Ferini-Strambi L, Ferri R, Tinazzi M.

Mov Disord Clin Pract. 2025 Jan;12(1):11-20. doi: 10.1002/mdc3.14254. Epub 2024 Nov 7.

Wnt/β-catenin Signaling in Central Nervous System Regeneration

Nazli D, Bora U, Ozhan G.

Adv Exp Med Biol. 2025;1474:13-33. doi: 10.1007/5584_2024_830.

Unraveling Neurological Drug Delivery: Polymeric Nanocarriers for Enhanced Blood-Brain Barrier Penetration

Inamdar A, Gurupadayya B, Halagali P, Tippavajhala VK, Khan F, Pathak R, Sharma H.

Curr Drug Targets. 2025;26(4):243-266. doi: 10.2174/0113894501339455241101065040.

The Varying Faces of MOGAD: A Case Series

Poovathingal MA.

Ann Afr Med. 2025 Jan 1;24(1):184-187. doi: 10.4103/aam.aam_159_24. Epub 2024 Nov 8.

Efficacy of Action Observation Therapy on Gait, Balance and Mobility Impairments: A Systematic Review and Meta-Analysis

Picardi M, Temporiti F, Salamone C, Tropea P, Buccino G, Corbo M, Gatti R.

Physiother Res Int. 2025 Jan;30(1):e70006. doi: 10.1002/pri.70006.

Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr Stimulation

Cebi I, Graf LH, Schütt M, Hormozi M, Klocke P, Löffler M, Schneider M, Warnecke T, Gharabaghi A, Weiss D.

Dysphagia. 2025 Aug;40(4):811-822. doi: 10.1007/s00455-024-10779-y. Epub 2024 Nov 9.

Postmortem evaluation of the striatum in an NTCELL trial participant five years after transplantation

Palpagama TH, Turner CP, Low VF, Faull RL, Curtis MA, Snow B.

Parkinsonism Relat Disord. 2025 Jan;130:107192. doi: 10.1016/j.parkreldis.2024.107192. Epub 2024 Nov 1.

Ferroptosis and cognitive impairment: Unraveling the link and potential therapeutic targets

Naderi S, Khodagholi F, Janahmadi M, Motamedi F, Torabi A, Batool Z, Heydarabadi MF, Pourbadie HG.

Neuropharmacology. 2025 Feb 1;263:110210. doi: 10.1016/j.neuropharm.2024.110210. Epub 2024 Nov 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias